Luqa Pharma Announces $15 Million Fundraising

Luqa Pharmaceuticals, a China in-licensing company that specializes in dermatolgy products, raised $15 million in a funding led by Morningside Ventures. The proceeds will be used to expand and develop Luqa’s product range. Luqa, whose base is in Shanghai, launched its first product in 2013 and now markets nine products in China. It expects to launch three more before the end of the year. More details.... Share this with colleagues: // //